Pneumonia in patients with hematological malignancies. Etiology, response to treatment and prognostic factors in 69 patients (88 episodes);Neumonías en los pacientes con hemopatías malignas. Etiología, respuesta al tratamiento y factores pronósticos en 69 pacientes (88 episodios)

Medicina Clinica

Volumn 112, Issue 9, 1999, Pages 321-325

  Fernández Avilés, Francisco ^a   Batlle, Montserrat ^a   Ribera Santasusana, Josep Maria ^a   Matas, Lourdes ^a   Rosell, Antoni ^a   Manzano, José Luis ^a   Flores, Alonso ^a   Millá, Fuensanta ^a   Feliu, Evarist ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD DISEASE; CHI SQUARE DISTRIBUTION; COMMUNICABLE DISEASE; CROSS INFECTION; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA; PROGNOSIS; STATISTICAL MODEL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PNEUMONIA; PROGNOSIS; TREATMENT OUTCOME;

EID: 0040883151     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Novákova I, Donnelly JP, De Pauw B. Potential sites of infection that develop in febrile neutropenic patients. Leuk Lymphoma 1993; 10: 461-467.
2. Bodey GP. Infection in cancer patients. A continuing association. Am J Med 1986; 81 (Supl 1A): 11-26.
3. Singer C, Kaplan MH. Armstrong D. Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am J Med 1977; 62: 731-742.
4. Tenholder MM, Hooper RG. Pulmonary infiltrates in leukemia. Chest 1980; 78: 468-473.
5. Pizzo PA. Management of fever in patients with cancer and treatment induced neutropenia. N Engl J Med 1993; 328: 1.323-1.332.
6. Maschmeyer G, Link H, Hiddemann W, Meyer P, Helmerking M, Eisenmann E et al. Pulmonary infiltrations in febrile patients with neutropenia. Cancer 1994; 73: 2.296-2.304.
7. Von Eiff M, Zühlsdrof M, Roos N, Thomas M, Büchner T, Van de Loo J. Pulmonary infiltrates in patients with haematologic malignancies: clinical usefulness of non-invasive bronchoscopic procedures. Eur J Haematol 1995; 45: 157-162.
8. Marra R, Pagano L, Pagliari G. The yield of bronchoalveolar lavage in the diagnosis of pneumonia in leukaemia and lymphoma patients. Eur J Haematol 1993; 51: 256-258.
9. Heurlin N, Brattström C, Lönnqvist B, Westman L, Lidman C, Andersson J. Aetiology of pulmonary diseases in immunocompromised patients. Eur Respir J 1991; 4: 10-18.
10. Kahn FW, Jones JM. Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis 1987; 155: 862-869.
11. McCabe RE, Brooks RG, Mark JB, Remington JS. Open lung biopsy in patients with acute leukemia. Am J Med 1985; 78: 609-616.
12. Scheld WM, Mandell GL. Nosocomial pneumonia: pathogenesis and recent advances in diagnosis and therapy. Rev Infect Dis 1991; 13 (Supl 9): 743-751.
13. Murray PR, Washington JA II. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 1975; 50: 339-344.
14. Cox DR. Regression modes and life tables. J Roy Stat Soc Series B 1972; 34: 187-220.
15. Viola MV. Acute leukemia and infection. JAMA 1967; 201: 923-926.
16. Viscoli C, Bruzzi P, Castagnola E. Factors associated with bacteremia in febrile, granulocytopenic cancer patients. Eur J Cancer 1994; 30A: 430-437.
17. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relation-ship between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328-340.
18. Wilhelm M, Kantajian HM, O'Brien S, Pierce S, Keating MJ, Freireich EJ et al. Pneumonia during remission induction chemotherapy in patients with AML or MDS. Leukemia 1996; 10: 1.870-1.873.
19. Charlock S. Evolving risk factors for infectious complications of cancer therapy. Hematol Oncol Clin North Am 1993; 7: 771-793.
20. Valsh TJ, Hiemenz J, Pizzo PA. Evolving risk factors for invasive fungal infections all neutropenic patients are not the same. Clin Infect Dis 1994; 18: 793-798.
21. Von Eiff M, Zühlsdorf M, Roos N, Hesse M, Schulten R, Van de Loo J. Pulmonary fungal infections in patients with hematological malignancies. Diagnostic approaches. Ann Hematol 1995; 70: 135-141.
22. Armstrong D. Problems in management of opportunistic fungal diseases. Rev Infect Dis 1989; 2 (Supl 7): 1.591-1.599.
23. Burnie JP. Developments in the serological diagnosis of opportunistic fungal infections. J Antimicrob Chemother 1991; 28 (Suppl A): 23-33.
24. Davies SF. Diagnosis of pulmonary fungal infections. Semin Respir Infect 1988; 3: 162-171.
25. Hopwood V, Warnock DW. New developments in the diagnosis of opportunistic fungal infection. Eur J Clin Microbiol 1986; 5: 379-388.
26. Schùrmann D, Ruf B, Pfannkuch F, Horbach I, Pohle HD. Fatal legionellosis in patients with malignant hematologic diseases. Blut 1988; 56: 27-31.
27. Fehrenbach FJ, Herbach I, Ruf B. Schürmann D, Pohle HL. Legionella antigen detection in body fluids and tissue homogenates. Isr J Med Sci 1986; 22: 706-710.
28. Kohler RB, Winn WC Jr, Wheat LJ. Onset and duration of urinary antigen excretion in Legionnaries disease. J Clin Microbiol 1984; 20: 505-507.
29. Domínguez JA, Matas L, Manterola JM, Blavia R, Sopena N, Belda FJ et al. Comparison of RIA and EIA tests for detection of Legionella pneumophila serogroup 1 in both concentrated and non-concentrated urine. J Clin Microbiol 1997; 5: 1.627-1.629.
30. Domínguez JA, Manterola JM, Blavia R, Sopena N, Belda FJ, Padilla E et al. Detection of Legionella pneumophila serogroup 1 antigen in non-concentrated urine and urine concentrated by selective ultrafiltration. J Clin Microbiol 1996; 34: 2.334-2.336.
31. Middleton R, Broughton WA, Kirkpatrick MB. Comparison of four methods for assessing airway bacteriology in intubated mechanically ventilated patients. Am J Med Sci 1992; 304: 239-245.
32. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator associated pneumonia by bacteriologic analysis of brorichoscopic and non-bronchoscopic «blind» bronchoalveolar lavage fluid. Am Rev Respir 1991; 143: 1.121-1.129.
33. Pennington JE, Feldman NT. Pulmonary infiltrates and fever in patients with hematologic malignancy. An J Med 1977; 62: 581-587.
34. McKenna RJ, Mountain CF, McMurtrey MJ. Open lung biopsy in immunocompromised patients. Chest 1984; 86: 671-674.
35. Bodey G, Buellmann B, Duguid W, Gibbs D, Hanak H. Fungal infections in cancer patients: an internal onal autopsy survey. Eur J Clin Microbiol Infect Dis 1992; 11: 99-109.
36. Baglin TP, Gray JJ, Marcus RE, Wreghitt TG. Antibiotic resistant fever associated with herpes virus infection in neutropenic patients with haematological malignancy. J Clin Pathol 1989; 42: 1.255-1.258.
37. Degregorio MW, Lee WM, Linker CA, Jacobs RA, Ries CA. Fungal infection in patients with acute leukemia. Am J Med 1982; 73: 543-548.
38. Pedro-Botet ML, Sabriá M, Espinosa L, Condom MJ, Carrasco I, Foz M. Utilidad de los marcadores epidemiologicos moleculares en el estudio de un brote epidémico de enfermedad del legionario de origen nosocomial. Med Clin (Barc) 1992; 99: 761-765.
39. Bodey GP. Patients with neutropenia: old and new treatment modalities. Empirical antibiotic therapy for fever in neutropenic patients. Clin Infect Dis 1993; 17(Sup: 2): 378-384.
40. Todeschini G, Veneri D, Carlini S, Pizzolo G, Ambrosetti A, Bonesi R et al. Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes. Hematol Oncol 1991; 9: 137-146.
41. EORTC International Antimicrobial Therapy Cooperative Group. Gram-positive bacteremia in granulocytopenic cancer patients. Eur J Cancer 1990; 26: 569-574.
42. Pedro-Botet ML, Sabriá M, Condom MJ, Espinosa L, Ruiz L, Arnal J et al. Utilidad del sistema API ZYM para la identificación de Legionella sp. Enferm Infecc Microbiol Clin 1993; 11: 131-134.
43. Peters SG, Meadows JA, Gracey DR. Outcome of respiratory failure in hematologic malignancy Chest 1988; 94: 99-102.
44. Schuster DP, Marion JM. Precedents for meaningful recovery during treatment in a medical intensive care unit: outcome in patients with hematologic malignancy. Am J Med 1983; 75: 402-408.
45. Estopa R, Marti AT, Kastanos N, Rives A, Agustí-Vidal A, Rozman C. Acute respiratory failure in severe hematologic disorders. Crit Care Med 1984; 12: 26-28.